Shares of Select Medical Holdings Corporation (NYSE:SEM – Get Free Report) have been assigned an average rating of “Hold” from the seven ratings firms that are covering the firm, MarketBeat reports. Six analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is $15.50.
Several brokerages recently issued reports on SEM. Zacks Research raised Select Medical from a “strong sell” rating to a “hold” rating in a research note on Monday, May 4th. Weiss Ratings raised shares of Select Medical from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, June 4th. Finally, Mizuho reaffirmed a “neutral” rating and set a $16.50 price objective (down from $17.00) on shares of Select Medical in a research note on Tuesday, May 12th.
Select Medical Stock Performance
Select Medical (NYSE:SEM – Get Free Report) last posted its quarterly earnings results on Thursday, April 30th. The health services provider reported $0.36 EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). Select Medical had a net margin of 2.42% and a return on equity of 6.62%. The firm had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.41 billion. During the same quarter in the previous year, the company earned $0.44 EPS. The company’s quarterly revenue was up 5.0% compared to the same quarter last year. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Equities research analysts anticipate that Select Medical will post 1.26 earnings per share for the current fiscal year.
Select Medical Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, May 28th. Shareholders of record on Thursday, May 14th were paid a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date was Thursday, May 14th. Select Medical’s dividend payout ratio is currently 23.58%.
Hedge Funds Weigh In On Select Medical
A number of large investors have recently bought and sold shares of SEM. Quarry LP acquired a new position in Select Medical during the 4th quarter valued at about $26,000. Caitong International Asset Management Co. Ltd acquired a new position in Select Medical during the fourth quarter valued at $28,000. Quantbot Technologies LP purchased a new stake in shares of Select Medical in the third quarter worth about $27,000. Hantz Financial Services Inc. grew its stake in shares of Select Medical by 214.7% during the 4th quarter. Hantz Financial Services Inc. now owns 2,549 shares of the health services provider’s stock worth $38,000 after purchasing an additional 1,739 shares during the period. Finally, Smartleaf Asset Management LLC grew its position in Select Medical by 37.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 2,870 shares of the health services provider’s stock valued at $43,000 after buying an additional 788 shares during the period. Institutional investors own 89.48% of the company’s stock.
About Select Medical
Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.
Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.
Further Reading
- Five stocks we like better than Select Medical
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.
